Braxia Scientific Corp. (BRAXF)
OTCMKTS
· Delayed Price · Currency is USD
0.0012
+0.0004 (33.33%)
May 12, 2025, 3:59 PM EDT
Braxia Scientific Income Statement
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Revenue | 2.21 | 1.88 | 1.49 | 1.01 | - |
| Revenue Growth (YoY) | 27.59% | 26.70% | 47.48% | - | - |
| Cost of Revenue | 1.89 | 1.71 | 1.24 | 0.86 | - |
| Gross Profit | 0.32 | 0.17 | 0.25 | 0.15 | - |
| Selling, General & Admin | 3.8 | 5.86 | 4.74 | 5.81 | 0.08 |
| Research & Development | 0.01 | 0.1 | 0.19 | 1.98 | 0.01 |
| Other Operating Expenses | -0 | -0 | -0 | -0 | - |
| Operating Expenses | 4.3 | 7.38 | 7.38 | 10.68 | 3.3 |
| Operating Income | -3.98 | -7.21 | -7.13 | -10.54 | -3.3 |
| Interest Expense | -0.06 | -0.02 | -0 | -0 | - |
| Earnings From Equity Investments | -0.03 | 0.02 | -0 | - | - |
| Currency Exchange Gain (Loss) | -0.03 | -0.03 | 0.01 | 0 | - |
| Other Non Operating Income (Expenses) | -0.16 | -0.22 | -0.02 | -0.12 | - |
| EBT Excluding Unusual Items | -4.25 | -7.46 | -7.16 | -10.66 | -3.3 |
| Merger & Restructuring Charges | - | - | - | -77.79 | - |
| Impairment of Goodwill | -3.72 | -3.72 | -5.28 | - | - |
| Asset Writedown | -1.75 | -1.75 | - | - | - |
| Legal Settlements | -0.06 | -0.06 | 0.21 | - | - |
| Other Unusual Items | - | -0.29 | 0.04 | - | - |
| Pretax Income | -9.79 | -13.29 | -12.18 | -88.45 | -3.3 |
| Income Tax Expense | -0.15 | -0.15 | -0.05 | - | - |
| Earnings From Continuing Operations | -9.64 | -13.14 | -12.13 | -88.45 | -3.3 |
| Earnings From Discontinued Operations | - | - | - | -0.38 | - |
| Net Income | -9.64 | -13.14 | -12.13 | -88.83 | -3.3 |
| Net Income to Common | -9.64 | -13.14 | -12.13 | -88.83 | -3.3 |
| Shares Outstanding (Basic) | 260 | 228 | 175 | 158 | 0 |
| Shares Outstanding (Diluted) | 260 | 228 | 175 | 158 | 0 |
| Shares Change (YoY) | 20.88% | 30.34% | 11.17% | 1015686.69% | - |
| EPS (Basic) | -0.04 | -0.06 | -0.07 | -0.56 | -212.66 |
| EPS (Diluted) | -0.04 | -0.06 | -0.07 | -0.56 | -212.66 |
| Free Cash Flow | -2.65 | -8.23 | -4.54 | -5.08 | -0.05 |
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.03 | -0.03 | -3.44 |
| Gross Margin | 14.67% | 9.12% | 16.60% | 14.45% | - |
| Operating Margin | -179.96% | -382.57% | -479.77% | -1045.10% | - |
| Profit Margin | -436.37% | -697.48% | -815.93% | -8809.07% | - |
| Free Cash Flow Margin | -119.78% | -436.60% | -305.52% | -503.59% | - |
| EBITDA | -3.71 | -6.68 | -7.12 | -10.54 | - |
| D&A For EBITDA | 0.26 | 0.53 | 0.01 | 0 | - |
| EBIT | -3.98 | -7.21 | -7.13 | -10.54 | -3.3 |
| Advertising Expenses | - | 0.15 | 0.25 | 1.85 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.